Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Boer

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Medicine|February 13, 2017
Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcomeMatthew T Witkowski, Yifang Hu, Kathryn G Roberts, et al.
Cancers|August 26, 2022
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary InvolvementEmma Kroeze, Laura Arias Padilla, Max Bakker, et al.
Blood|April 22, 2020
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemiaAmir Enshaei, David O'Connor, Jack Bartram, et al.
Haematologica|December 17, 2016
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patientsBlanca Scheijen, Judith M Boer, René Marke, et al.
Haematologica|June 6, 2024
<i>IKZF1</i> gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemiaBritt M T Vervoort, Miriam Butler, Kari J T Grünewald, et al.
The Lancet. Haematology|September 24, 2021
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort studyNaomi Michels, Judith M Boer, Amir Enshaei, et al.
Haematologica|April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignanciesUri Ilan, Judith M Boer, Maaike Luesink, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Plos One|January 17, 2012
Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7RWillemijn M Passtoors, Judith M Boer, Jelle J Goeman, et al.
Leukemia|March 11, 2021
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working GroupShinsuke Hirabayashi, Ellie R Butler, Kentaro Ohki, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|February 13, 2017
Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcomeMatthew T Witkowski, Yifang Hu, Kathryn G Roberts, et al.
Cancers|August 26, 2022
Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary InvolvementEmma Kroeze, Laura Arias Padilla, Max Bakker, et al.
Blood|April 22, 2020
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemiaAmir Enshaei, David O'Connor, Jack Bartram, et al.
Haematologica|December 17, 2016
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patientsBlanca Scheijen, Judith M Boer, René Marke, et al.
Haematologica|June 6, 2024
<i>IKZF1</i> gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemiaBritt M T Vervoort, Miriam Butler, Kari J T Grünewald, et al.
The Lancet. Haematology|September 24, 2021
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort studyNaomi Michels, Judith M Boer, Amir Enshaei, et al.
Haematologica|April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignanciesUri Ilan, Judith M Boer, Maaike Luesink, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Plos One|January 17, 2012
Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7RWillemijn M Passtoors, Judith M Boer, Jelle J Goeman, et al.
Leukemia|March 11, 2021
Clinical characteristics and outcomes of B-ALL with ZNF384 rearrangements: a retrospective analysis by the Ponte di Legno Childhood ALL Working GroupShinsuke Hirabayashi, Ellie R Butler, Kentaro Ohki, et al.
Pageof 10